DARA BioSciences, Inc. Reports Financial Results for the First Quarter 2012 and Provides Key Highlights of the Company's Business Milestonesd

Published: May 21, 2012

RALEIGH, N.C., May 21, 2012 (GLOBE NEWSWIRE) -- DARA BioSciences, Inc. (Nasdaq:DARA) (the "Company" or "DARA") today announced the financial results for the period ending March 31, 2012. The Company also detailed the quarter's key corporate activities, including an overview of the commercial portfolio, which includes two FDA-registered products for the oncology and oncology supportive care markets.

Back to news